BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260304T081744EST-8854b1F7gu@132.216.98.100
DTSTAMP:20260304T131744Z
DESCRIPTION:Abstract: \n\nChemical synthesis and data science are two field
 s that operate in synergy. Molecules and the routes to synthesize them are
  easily represented as graphs while automated chemical synthesis strategie
 s allow more and more synthesis data to be captured\, for instance to feed
  machine learning algorithms. This talk will detail our work in the merger
  of chemical synthesis and data science focusing on a new class of amine-a
 cid cross coupling reactions\, and the computer-assisted synthesis of drug
 s and natural products. We have been exploring the breadth of all reaction
 s that could exist\, navigating combinatorial explosions of virtual and pl
 ausible reaction methods\, routes to complex molecules\, and the interconn
 ectedness of reaction conditions\, transformations\, and biological functi
 ons for medicinal chemistry. Our agnostic view of reactions and their mech
 anisms has recently extended to diseases\, with a focus on One Health. We 
 aspire to produce medicines and treatments for exotic disease challenges i
 n endangered species. We call this new area conservation chemistry\, and e
 xamples from the frontlines of this field and lab-based research will be s
 hared.\n\n \n\nBio:\n\nTim Cernak was born in Montreal\, Canada in 1980. H
 e obtained a B.Sc. in Chemistry from University of British Columbia Okanag
 an and there studied the aroma profile of Chardonnay wines. Following PhD 
 training in total synthesis with Prof. Jim Gleason at 91Ë¿¹ÏÊÓƵ\, 
 Tim was a FQRNT Postdoctoral Fellow with Tristan Lambert at Columbia Unive
 rsity. From 2009–2018\, Tim worked with the Medicinal Chemistry team at Me
 rck Sharp & Dohme in Rahway and Boston. In 2018\, Dr. Cernak joined the De
 partment of Medicinal Chemistry at the University of Michigan in Ann Arbor
  as an Assistant Professor. The Cernak Lab is exploring an interface of ch
 emical synthesis and AI for drug discovery. Tim is developing research in 
 conservation chemistry\, where chemists engage in preventing species extin
 ction. Tim has received fellowships from the Alfred P. Sloan\, Kavli Found
 ation\, Anchor Point\, Hypothesis Fund and Schmidt Futures Foundations. He
  has served on Scientific Advisory Boards for Scorpion Therapeutics\, The 
 Open Reaction Database\, the Dundee Drug Discovery Unit\, and the Accelera
 tion Consortium Medicinal Chemistry Self-Driving Lab. Tim is a co[1]Founde
 r of Iambic\, Inc. He is a Research Fellow of Smithsonian’s National Zoo a
 nd Conservation Biology Institute.\n
DTSTART:20260217T180000Z
DTEND:20260217T193000Z
LOCATION:OM 10\, Maass Chemistry Building\, CA\, QC\, Montreal\, H3A 0B8\, 
 801 rue Sherbrooke Ouest
SUMMARY:91Ë¿¹ÏÊÓƵ Chemical Society Seminar Series- Timothy Cernak: Combinatori
 al explosion: from atom-bond arrangements to exotic diseases
URL:/chemistry/channels/event/mcgill-chemical-society-
 seminar-series-timothy-cernak-combinatorial-explosion-atom-bond-arrangemen
 ts-371195
END:VEVENT
END:VCALENDAR